Welcome to NewsQuantified for 2018. We’re excited to see the news-based trading strategies that will enable another profitable year begin to come into focus.
Markets are entering 2018 after a long bull run in 2017. While the overall macro environment remains mostly positive, investors may have their fingers on the selling trigger as valuations become increasingly high.
For now, however, traders appear to be trading near the trendline, just as in the closing weeks of December. Stocks are up modestly on the day.
In another continuing trend from last year, today’s Top Performer is a pharma stock that managed to pierce the sluggish momentum to register some dramatic same-day gains.
Midatech Pharma is an international specialty pharmaceuticals company focused on the oncology market.
Their stock shot up today after they announced they have arrived at terms for a secured loan from Midcap Financial. Their agreement provides for a lending facility up to $15 million. $7 million will become available immediately as the first tranche of the loan.
The remainder of the funding is tied to milestones in the development of some of Midatech’s most promising potential product lines. MTP’s flagship products all focus on improved drug delivery for oncology therapies: gold nanoparticles (enabling precision delivery), polymer microspheres (enabling more sustained delivery), and “Nano Inclusion Technology” (designed to improve highly localized delivery, especially in the brain).
Investors piled into the stock on the news; it was up 120% at the time of this writing, even after pulling back from gains well over 200%.
Pharmaceutical financing agreements like this one drive stock value on multiple fronts. Most obviously, they provide key working capital for the company in question. And—far more importantly—they act as a powerful signal investors, who now know a major investment firm has done their due diligence on MTP and liked what they saw.
Diverse Plays, Great Profits: All in a single news day.
Keep checking our blog for daily updates on lucrative new-based stock plays, analyst actions, and more!
We analyze news events ranging from clinical trials in the pharmaceutical industry to routine earnings releases to major geopolitical shakeups.
Or, if you’re ready to move beyond the blog and experience the power of hedge-fund caliber news analysis in a package that’s accessible to small investors, click here to sign up for a free training today. You’ll see how easy to use our platform really is—and how many profitable trades it can unlock
A powerful news analytics platform like NewsQuantified not only makes it easy to track the news, but to quickly compare news events with key financial information. We make it simple to find strong, diverse plays in any market environment.
How are you using the news to earn market-beating profits? How would you use the news if you had access to a real-time platform like NewsQuantified? Let us know in the comments below.